Effect of Intravenous Lidocaine Infusion on Long Term Postoperative Pain After Spinal Fusion Surgery
Overview
- Phase
- Phase 2
- Intervention
- Lidocaine
- Conditions
- Postoperative Pain
- Sponsor
- Abdelrady S Ibrahim, MD
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- numerical rating scale (NRS), pain score.
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Spinal fusion is a painful surgery, and control of postoperative pain is difficult. Several studies have indicated that appropriate pain treatment protocols reduce postoperative morbidity, improve the results of the surgery, and decrease hospital costs
Detailed Description
Forty four patients were randomly allocated into two groups of equal size to receive either lidocaine infusion (Lidocaine group) or 0.9% sodium chloride infusion (Control group). Randomization: was performed using Lidocaine group and Control group registers, which was placed in sealed envelopes prior to study initiation and opened prior to anesthesia by a physician who prepared the intravenous solution and identified it with the patient number, according to the envelope drawn. The solution was handed to another physician, blind to the prepared solutions' content, who was responsible for the anesthesia. The solution volume was equal. The responsible investigator was remained blind to the chosen group until the end of the study.
Investigators
Abdelrady S Ibrahim, MD
Assistant professor of anesthesia and ICU
Assiut University
Eligibility Criteria
Inclusion Criteria
- •Age \> 18 years American Society of Anesthesiologists 1-3 status Patients undergoing spinal fusion or fixation
Exclusion Criteria
- •Previous spinal fusion surgery.
- •Morbid obesity (BMI \> 40)
- •Diagnosis of spinal metastatic cancer
- •Allergy to an amide local anesthetic or morphine sulfate
- •History of renal dysfunction, liver dysfunction or congestive heart failure
- •History of substance abuse disorder.
- •Chronic opioid use.
Arms & Interventions
Lidocaine group
Patients will receive lidocaine infusion.
Intervention: Lidocaine
Control group
Patients will receive 0.9% Sodium-chloride infusion infusion
Intervention: 0.9% Sodium-chloride
Outcomes
Primary Outcomes
numerical rating scale (NRS), pain score.
Time Frame: Postoperative 3 months
Postoperative numerical rating scale (NRS), pain score.
Secondary Outcomes
- opioid consumption.(Postoperative 24 h)
- Serum cortisol.(Postoperative 24 h)